Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts

OBJECTIVES: To analyse the section of Disclosure UK that pertains to healthcare professionals (HCPs) in order to provide insight into the database’s structure and content and suggest ways to improve its transparency. DESIGN AND PARTICIPANTS: Cohort study of drug companies and HCPs in the 2015 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulinari, Shai, Ozieranski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196800/
https://www.ncbi.nlm.nih.gov/pubmed/30344175
http://dx.doi.org/10.1136/bmjopen-2018-023094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196800/
https://www.ncbi.nlm.nih.gov/pubmed/30344175
http://dx.doi.org/10.1136/bmjopen-2018-023094

Ejemplares similares